Head & Face Medicine, published by BMC, serves as a vital open-access platform for advancing research and clinical practices in the fields of Dentistry, Otorhinolaryngology, and Neurology. Since its inception in 2005, this journal has nurtured contributions that span a diverse range of topics, making significant strides in understanding complex head and facial conditions. With an impressive categorization in the 2023 Journal Rankings, where it is recognized in Q1 for both Dentistry and Otorhinolaryngology, as well as Q2 for Neurology, it holds a prestigious position in the academic community, fostering innovative ideas and collaborations. The journal's commitment to free access ensures widespread availability of groundbreaking research, promoting knowledge dissemination among researchers, healthcare professionals, and students alike. Located in the United Kingdom and continuously prioritizing rigorous peer review, Head & Face Medicine is essential for anyone seeking to stay at the forefront of medical advancements concerning head and facial health.

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

Journal of Otolaryngology-Head & Neck Surgery, published by SAGE Publications Inc, stands at the forefront of research in the fields of otorhinolaryngology and surgery. With an impressive Q1 ranking in both categories, this open-access journal, available since 2013, facilitates the dissemination of cutting-edge findings that enhance our understanding of complex head and neck disorders. Situated in the United Kingdom, the journal provides a vital platform for researchers, clinicians, and students to contribute to and engage with innovative therapeutic strategies and surgical techniques. The impact factor, underscored by its robust placement in Scopus rankings—7th among 123 in otorhinolaryngology and 35th among 551 in surgery—reflects its critical role in advancing evidence-based practice and informing clinical decisions globally. Covering a wide array of topics from basic science to practical implications, the journal is committed to fostering a collaborative and dynamic research environment.

Welcome to the Australian Journal of Otolaryngology, a premier resource in the field of Otorhinolaryngology, published by AME Publishing Company. Established in 2018, this journal continues to be a vital platform for disseminating groundbreaking research and advancements in ear, nose, and throat medicine. With its commitment to open access, the journal strives to ensure that high-quality research is widely available to practitioners, researchers, and students alike. Positioned in the Q3 category for Otorhinolaryngology as of 2023, the journal is ranked #94 out of 123 in Scopus, indicating its increasing recognition in the academic community. The editorial board comprises distinguished experts dedicated to enhancing the understanding of otolaryngological disorders and treatments. We invite you to explore the latest findings and contribute to the growth of this dynamic field through your submissions.

AURIS NASUS LARYNX, published by Elsevier Science Ltd, is a leading peer-reviewed journal specializing in the fields of otorhinolaryngology, surgery, and general medicine. Since its inception in 1974, this esteemed journal has been committed to disseminating high-quality research and innovative findings pertinent to the diagnosis, treatment, and management of ear, nose, and throat diseases. With an impressive 2023 impact factor reflected in its Q2 quartile rankings in both Medicine (miscellaneous) and Otorhinolaryngology, as well as its strong position in Surgery, AURIS NASUS LARYNX is regarded highly among researchers and practitioners. The journal is accessible through a subscription model, ensuring that essential knowledge remains within reach for both clinical and academic pursuits. The continuous evolution of its content promises to stay at the forefront of medical advancements, making it an invaluable resource for scholars, clinicians, and students striving for excellence in the medical field.

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

Chirurgia-Italy, an esteemed publication in the field of Surgery, is published by EDIZIONI MINERVA MEDICA. Since its inception in 1973, it has become a platform for disseminating significant findings and advancements in surgical practice, evidenced by its continuous publication history through various converged years up until 2024. Although currently classified in the Q4 category of surgery journals in 2023, and ranking within the 3rd percentile in Scopus with respect to medicine and surgery, its role in enriching the surgical community with critical insights remains vital. Researchers, practitioners, and students alike will find valuable information and discussions pertinent to contemporary surgical techniques and methodologies. While the journal does not operate under an open access model, its content is nonetheless indispensable for those looking to stay informed about the latest developments in the surgical landscape.

Current Opinion in Otolaryngology & Head and Neck Surgery is a distinguished journal published by Lippincott Williams & Wilkins, aimed at advancing the field of otolaryngology. With an ISSN of 1068-9508 and an E-ISSN of 1531-6998, this journal delivers insightful reviews and critical analyses of contemporary research developments in otolaryngology and head and neck surgery. The journal holds a commendable Q2 ranking in both the fields of Medicine (miscellaneous) and Otorhinolaryngology, as well as in Surgery, according to the 2023 Category Quartiles. Its Scopus rankings further underscore its credibility, positioned at #199 in Medicine Surgery and #54 in Otorhinolaryngology. Established since 1995 and set to continue through 2024, Current Opinion in Otolaryngology & Head and Neck Surgery serves as a crucial resource for researchers, clinicians, and students seeking to stay informed on the latest trends and innovations in the field. While not an open-access journal, it offers a subscription model that grants access to high-quality, peer-reviewed content essential for professional development and academic excellence.

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.